Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdated the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Gorlin syndrome as a related term and included the Genetic and Rare Diseases Information Center as a new resources link.SummaryDifference0.2%

- Check49 days agoChange DetectedSite revision updated to version 3.5.0 and previous version 3.4.3 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3, indicating a system update. No substantive study information or eligibility details were altered.SummaryDifference0.1%

- Check84 days agoChange DetectedAn updated site revision tag is visible (Revision: v3.4.2), and the previous funding notice and earlier revision tag (v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.